About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cholesterol-Lowering Pitavastatin Tablet Gets USFDA Approval

by Madhumathi Palaniappan on December 31, 2016 at 9:44 AM
Font : A-A+

Cholesterol-Lowering Pitavastatin Tablet Gets USFDA Approval

The United States Food and Drug Administration (USFDA) has tentatively approved the cholesterol lowering Pitavastatin tablets from Lupin Pharmaceuticals.

"Pharma Major Lupin announced today that it has received tentative approval for its Pitavastatin tablets, 1 mg, 2 mg and 4 mg from the United States Food and Drug Administration (FDA) to market a generic version of Kowa Company Limited's (Kowa) Livalo Tablets 1 mg, 2 mg and 4 mg," the pharmaceutical company said in a regulatory filing to the BSE.

Advertisement


"Pitavastatin tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia," it added.



Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Drug - Food Interactions Sinopril (2mg) (Lacidipine) Selfie Addiction Calculator Sanatogen Loram (2 mg) (Lorazepam) Find a Doctor Iron Intake Calculator Color Blindness Calculator Hearing Loss Calculator Post-Nasal Drip
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use